miR‑155‑5p downregulation inhibits epithelial‑to‑mesenchymal transition by targeting SIRT1 in human nasal epithelial cells
Authors:
Open Access
- 27 August 2020
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 22 (5) , 3695-3704
Abstract
Epithelial-to-mesenchymal transition (EMT) in nasal epithelial cells is involved with tissue remodeling of nasal polyps. The present study investigated the molecular mechanisms through which miR‑155‑5p regulated EMT in chronic rhinosinusitis (CRS). Patients were divided into the following groups: CRSsNP, CRS without nasal polyposis group, CRSwNP, CRS with nasal polyposis and controls. The expression of transforming growth factor (TGF)‑β1, EMT markers, sirtuin 1 (SIRT1) and miR‑155‑5p were determined by western blotting and reverse transcription‑quantitative PCR. Cell morphology following TGF‑β1 treatment in the presence of miR‑155‑5p inhibitors or controls was observed under a microscope. Target genes and potential binding sites between miR‑155‑5p and SIRT1 were predicted by TargetScan and confirmed using dual‑luciferase reporter assay. In patients with CRS, the expression levels of E‑cadherin were downregulated and the expression levels of TGF‑β1, mesenchymal markers and miR‑155‑5p were upregulated. Additionally, these changes in expression levels were reduced or increased to a greater extent in the CRSwNP group compared with the CRSsNP group. Furthermore, TGF‑β1 expression promoted EMT in human nasal epithelial cells (HNEpCs) and upregulated miR‑155‑5p expression. These effects were reversed by miR‑155‑5p inhibitors. Additionally, SIRT1 was predicted as a target gene of miR‑155‑5p. Downregulation of miR‑155‑5p upregulated epithelial marker expression and downregulated mesenchymal marker expression by regulating SIRT1. Therefore, the downregulation of miR‑155‑5p inhibited EMT in HNEpCs by targeting SIRT1.Keywords
This publication has 49 references indexed in Scilit:
- Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transitionJournal of Allergy and Clinical Immunology, 2016
- TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial–mesenchymal transition and cancer stem cell phenotypesCancer Letters, 2015
- Features of mesenchymal transition in the airway epithelium from chronic rhinosinusitisAllergy, 2014
- Mechanisms of Airway RemodelingChest, 2013
- Chronic rhinosinusitis and emerging treatment optionsInternational Journal of General Medicine, 2013
- TGF-β-activated kinase-1: New insights into the mechanism of TGF-β signaling and kidney diseaseKidney Research and Clinical Practice, 2012
- Chronic Rhinosinusitis as a Multifactorial Inflammatory DisorderCurrent Infectious Disease Reports, 2011
- Validating the Use of Report-Derived Lund-MacKay ScoresAmerican Journal of Rhinology & Allergy, 2009
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Symptom scores as measures of the severity of rhinitisClinical & Experimental Allergy, 1988